Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults [Phase 1]
This Phase 1 trial comparing plasma concentrations of a hydrocodone/acetaminophen tablet from a new formulation versus a marketed tablet, un…
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3 [Phase 2]
Phase 2 trial of buprenorphine/naloxone for heroin dependence has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects [Phase 3]
A Phase 3 clinical trial evaluating buprenorphine/naloxone buccal film to initiate treatment in individuals with opioid use disorder has bee…
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 [Phase 2]
A Phase 2 trial of buprenorphine/naloxone for heroin dependence and opioid-related disorders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2 [Phase 2]
A Phase 2 clinical trial of buprenorphine/naloxone for heroin dependence conducted by the University of Colorado, Denver was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5 [Phase 2]
A Phase 2 trial of Buprenorphine/Naloxone for heroin dependence and opioid use disorders was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-06Clinical Trial Update: Neurobiology of Opioid Dependence: 3 - 3 [Phase 2]
A Phase 2 clinical trial investigating the neurobiology of opioid dependence has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Neurobiology of Opioid Dependence: 1 - 1 [Phase 2]
A Phase 2 trial investigating the neurobiology of opioid dependence sponsored by Yale University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Neurobiology of Opioid Dependence: 2 - 2 [Phase 2]
A Phase 2 clinical trial on neurobiology of opioid dependence sponsored by Yale University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Neurobiology of Opioid Dependence: 5 - 5 [Phase 2]
A Phase 2 clinical trial update on the neurobiology of opioid dependence has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-15Clinical Trial Update: Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India [Phase 2, Phase 3]
A Phase 2/Phase 3 trial of directly administered antiretroviral therapy for HIV-1 infected injecting drug users in Chennai, India has been w…
-
CLINICAL_TRIALS withdrawal · 2014-06-10Clinical Trial Update: Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Phase 4]
A Phase 4 clinical trial comparing buprenorphine/naloxone with naltrexone in opioid-dependent adolescents has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-22Clinical Trial Update: Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). [NA]
A clinical trial evaluating a primary care model for treating opioid use disorder with the long-acting injectable naltrexone (Vivitrol) has …